EpCAM is a new potential serum biomarker for early gastric cancer

被引:1
作者
Eroglu, Ersan [1 ,5 ]
Kiziltan, Remzi [2 ]
Algul, Sermin [3 ]
Kemik, Ozgur [4 ]
Altinli, Ediz [1 ]
机构
[1] Mem Bahcelievler Hosp, Dept Gen Surg, Istanbul, Turkiye
[2] Van Yuzuncu Yil Univ, Fac Med, Dept Gen Surg, Van, Turkiye
[3] Van Yuzuncu Yil Univ, Fac Med, Dept Physiol, Van, Turkiye
[4] Altinbas Univ Bahcelievler Med Pk Hosp, Dept Gen Surg, Istanbul, Turkiye
[5] Mem Bahcelievler Hosp, Dept Gen Surg, Istanbul, Turkiye
来源
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE | 2023年 / 14卷 / 03期
关键词
Gastric Cancer; TNM; EpCAM; Biomarker; ADHESION MOLECULE; STAGE-II; EXPRESSION; PROGNOSIS; COLON; CELLS;
D O I
10.4328/ACAM.21595
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Overexpression of epithelial cell adhesion molecule (EpCAM) has been shown in a wide spectrum of epithelial cancers. In this study we aimed to examine the utility of serum EpCAM levels as a new marker for early diagnosis of gastric cancer, and to determine its association with different stages of gastric cancer. Material and Methods: A total of 88 patients who underwent resection due to gastric cancer and 44 healthy subjects as the control group were included in the study. The diagnosis of gastric cancer was confirmed by a combination of upper gastrointestinal endoscopy, endoscopic ultrasonography, and histopathology. EpCAM levels were evaluated using the enzyme-linked immunosorbent assay (ELISA) method following the instructions of the manufacturer. Results: The mean preoperative EpCAM level was found as 235.7 +/- 34.2 pg/mL in the patient group and 42.5 +/- 2.38 pg/mL in the control group. The mean preoperative serum EpCAM level was found to be significantly higher in gastric cancer patients compared to the control group (p<0.001). In addition, mean EpCAM levels were higher in patients with class T4 and T2 compared to T1. Mean EpCAM levels were also significantly higher in N1 and N2 classes compared to N0, and in M1 compared to M0 (all, p<0.001). Discussion: The results of this study indicate that the elevated expression of the EpCAM levels can predispose to the development of gastric cancer. Thus, the analysis of this marker could be a useful biomarker for screening patients with gastric cancer.
引用
收藏
页码:267 / 270
页数:4
相关论文
共 50 条
[41]   Gastric juice microRNA-421 is a new biomarker for screening gastric cancer [J].
Zhang, Xinjun ;
Cui, Long ;
Ye, Guoliang ;
Zheng, Tuo ;
Song, Haojun ;
Xia, Tian ;
Yu, Xiuchong ;
Xiao, Bingxiu ;
Le, Yanping ;
Guo, Junming .
TUMOR BIOLOGY, 2012, 33 (06) :2349-2355
[42]   MicroRNA-548q is a novel oncogene and potential prognostic biomarker in human gastric cancer [J].
Liu, Jiahua ;
Ni, Xingzhi .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03) :2689-2700
[43]   MLKL is a potential prognostic marker in gastric cancer [J].
Sun, Wei ;
Yu, Wenyan ;
Shen, Lili ;
Huang, Tieao .
ONCOLOGY LETTERS, 2019, 18 (04) :3830-3836
[44]   S100A6 as a Potential Serum Prognostic Biomarker and Therapeutic Target in Gastric Cancer [J].
Jianli Zhang ;
Kejun Zhang ;
Xiuli Jiang ;
Jian Zhang .
Digestive Diseases and Sciences, 2014, 59 :2136-2144
[45]   LncRNA HCP5: A Potential Biomarker for Diagnosing Gastric Cancer [J].
Qin, Shiyi ;
Yang, Lei ;
Kong, Shan ;
Xu, Yanhua ;
Liang, Bo ;
Ju, Shaoqing .
FRONTIERS IN ONCOLOGY, 2021, 11
[46]   AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer [J].
Nakamura, Shunsuke ;
Kanda, Mitsuro ;
Shimizu, Dai ;
Tanaka, Chie ;
Inokawa, Yoshikuni ;
Hattori, Norifumi ;
Hayashi, Masamichi ;
Yamada, Suguru ;
Nakayama, Goro ;
Omae, Kenji ;
Koike, Masahiko ;
Kodera, Yasuhiro .
ANTICANCER RESEARCH, 2020, 40 (12) :6713-6721
[47]   Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer [J].
Li, Ye ;
Sun, Huihui ;
Guan, Jie ;
Ji, Tingting ;
Wang, Xinwei .
YONSEI MEDICAL JOURNAL, 2019, 60 (08) :720-726
[48]   Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer [J].
Eom, Bang Wool ;
Ryu, Keun Won ;
Yoon, Hong Man ;
Kook, Myeong-Cherl .
CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (05) :614-620
[49]   Comprehensive assessment of serum 3′-tRFArg as a novel diagnostic biomarker for gastric cancer [J].
Ding, Rui ;
Li, Yang ;
Zhang, Yu ;
Li, Xun ;
Song, Yunjian ;
Gu, Xinliang ;
Shen, Xianjuan ;
Ju, Shaoqing .
TRANSLATIONAL ONCOLOGY, 2025, 54
[50]   RETRACTED ARTICLE: EpCAM: A Potential Antimetastatic Target for Gastric Cancer [J].
Wenqi Du ;
Hongzan Ji ;
Shanshan Cao ;
Li Wang ;
Feihu Bai ;
Jie Liu ;
Daiming Fan .
Digestive Diseases and Sciences, 2010, 55 :2165-2171